June 9, 2020 / 6:16 AM / 23 days ago

BRIEF-Luye Pharma Group Gets Approval For Initiating Clinical Trial For Denosumab Injection In U.S.

June 9 (Reuters) - Luye Pharma Group Ltd:

* RECOMBINANT ANTI-RANKL FULLY HUMAN MONOCLONAL ANTIBODY INJECTION GOT APPROVAL FROM U.S. FDA TO INITIATE CLINICAL TRIALS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below